New-Generation Drug-Eluting Stents: Focus on Xience V® Everolimus-Eluting Stent and Resolute® Zotarolimus-Eluting Stent

被引：6
|
作者：
Van Dyck, Christophe J. [1 ,2 ]
Hoymans, Vicky Y. [1 ,2 ]
Haine, Steven [1 ,2 ]
Vrints, Christiaan J. [1 ,2 ]
机构：
[1] Univ Antwerp Hosp, Dept Cardiol, Lab Cellular & Mol Cardiol, B-2650 Antwerp, Belgium
[2] Univ Antwerp, Dept Translat Pathophysiol Res, B-2020 Antwerp, Belgium
来源：
JOURNAL OF INTERVENTIONAL CARDIOLOGY | 2013年 / 26卷 / 03期
关键词：
RANDOMIZED CONTROLLED-TRIAL; CORONARY-ARTERY-DISEASE; CLINICAL FOLLOW-UP; ACUTE MYOCARDIAL-INFARCTION; ONE-YEAR OUTCOMES; ENDEAVOR ZOTAROLIMUS; VASCULAR SCAFFOLD; UNRESTRICTED USE; SPIRIT V; SYSTEM;
D O I：
10.1111/joic.12028
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Compared to bare metal stent angioplasty, first-generation drug-eluting stents (DES) have markedly reduced the incidence of in-stent restenosis. However, given the increased concerns over late and very late stent thrombosis, newer-generation DES were developed. To date, these DES have virtually replaced the use of first-generation DES worldwide. In this review article, we carefully consider the pre-clinical and clinical trials that have been performed with currently available, european conformity-marked and Food and Drug Administration-approved new-generation Resolute (R) and Xience V (R) DES. (J Interven Cardiol 2013;26:278-286)
引用
收藏
页码：278 / 286
页数：9
相关论文
共 50 条
  • [31] Two-year clinical outcomes of patients with overlapping second-generation drug-eluting stents for treatment of long coronary artery lesions: comparison of everolimus-eluting stents with resolute zotarolimus-eluting stents
    Li, Xiao-tao
    Sun, Hao
    Zhang, Da-peng
    Xu, Li
    Ni, Zhu-hua
    Xia, Kun
    Liu, Yu
    Chi, Yong-hui
    He, Ji-fang
    Li, Wei-ming
    Wang, Hong-shi
    Wang, Le-feng
    Yang, Xin-chun
    [J]. CORONARY ARTERY DISEASE, 2014, 25 (05) : 405 - 411
  • [32] Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform
    Whitbeck, Matthew G.
    Applegate, Robert J.
    [J]. CLINICAL MEDICINE INSIGHTS-CARDIOLOGY, 2013, 7 : 115 - 126
  • [33] Safety and Efficacy of the Xience Everolimus Eluting Stent Compared to First-Generation Drug-Eluting Stents in Contemporary Clinical Practice
    Barbash, Israel M.
    Torgusson, Rebecca
    Ben-Dor, Itsik
    Maluenda, Gabriel
    Xue, Zhenyi
    Suddath, William O.
    Satler, Lowell F.
    Kent, Kenneth M.
    Pichard, Augusto D.
    Waksman, Ron
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B60 - B61
  • [34] Atherosclerotic Change at One Year After Implantation of Endeavor Zotarolimus-Eluting Stent vs. Everolimus-Eluting Stent
    Akazawa, Yasuhiro
    Matsuo, Koshi
    Ueda, Yasunori
    Nishio, Mayu
    Hirata, Akio
    Asai, Mitsutoshi
    Nemoto, Takayoshi
    Wada, Mitsuru
    Murakami, Ayaka
    Kashiwase, Kazunori
    Kodama, Kazuhisa
    [J]. CIRCULATION JOURNAL, 2014, 78 (06) : 1428 - 1436
  • [35] Differential responses of local coagulation after implantation of everolimus-eluting and zotarolimus-eluting stents compared with early-generation drug-eluting stents in patients with stable angina
    Yamaguchi, K.
    Wakatsuki, T.
    Niki, T.
    Taketani, Y.
    Ise, T.
    Yagi, S.
    Iwase, T.
    Yamada, H.
    Soeki, T.
    Sata, M.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 : 550 - 550
  • [36] Comparison of Conformability and Wall Shear Stress Between Resolute Integrity Zotarolimus-Eluting Stent and the XIENCE Xpedition Everolimus-Eluting Stent in Angulated Vessels: An Interim Analysis of the SHEAR-STENT Randomized Controlled Study
    Kumar, Arnav
    Molony, David
    Raad, Mohamad
    Hosseini, Hossein
    Lee, Won
    Thompson, Elizabeth
    Lefieux, Adrien
    Hung, Olivia
    Machado, Kalina
    Kumar, Sonali
    Khawaja, Sameer
    Sternheim, David
    Vasigh, Mostafa
    Gupta, Sonu
    Gogas, Bill
    Veneziani, Alessandro
    Lee, Joo Myung
    Chen, Shao-Liang
    Otake, Hiromasa
    Akasaka, Takashi
    Shin, Eun-Seok
    Koo, Bon-Kwon
    Stankovic, Goran
    Milasinovic, Dejan
    Erglis, Andrejs
    Chandran, Karthic
    Nam, Chang-Wook
    Escaned, Javier
    Erglis, Andrejs
    Giddens, Don P.
    Samady, Habib
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B265 - B265
  • [37] Drug-eluting stents for the treatment of chronic total occlusion: a comparison with sirolimus, paclitaxel, zotarolimus (endeavor resolute), biolimusA9, EPC capture and everolimus-eluting stent
    Nakamura, S.
    Nakamura, S.
    Ogawa, H.
    Bae, J. H.
    Cahyadi, Y. H.
    Udayachalerm, W.
    Tresukosol, D.
    Tansuphaswadikul, S.
    [J]. EUROPEAN HEART JOURNAL, 2010, 31 : 994 - 994
  • [38] A comparison of drug eluting stent biocompatibility between third generation NOBORI biolimus A9-eluting stent and second generation XIENCE V everolimus-eluting stent in a porcine coronary artery model
    Sumida, Arihiro
    Gogas, Bill D.
    Nagai, Hiroyuki
    Li, Jinsheng
    King, Spencer B., III
    Chronos, Nicolas
    Hou, Dongming
    [J]. CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2015, 16 (06) : 351 - 357
  • [39] Drug-eluting stents for the treatment of small coronary artery with Sirolimus, Paclitaxel, Zotarolimus, EPC capture and Everolimus-eluting stent: multicenter registry
    Nakamura, S.
    Ogawa, H.
    Bae, J. H.
    Cahyadi, Y. H.
    Udayachalerm, W.
    Tresukosol, D.
    Tansuphaswadikul, S.
    [J]. EUROPEAN HEART JOURNAL, 2009, 30 : 786 - 786
  • [40] Final 5-Year Outcome After Implantation of Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in the Broad Patient Population of the Randomized TWENTE Trial
    von Birgelen, Clemens
    van der Heijden, Liefke C.
    Kok, Marlies M.
    van Houwelingen, Gert
    Stoel, Martin G.
    de Man, Frits H.
    Louwerenburg, Hans W.
    Linssen, Gerard C.
    Tandjung, Kenneth
    Basalus, Mounir W.
    van der Palen, Job
    Lowik, Marije M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B232 - B232
12345